Signal Transducer and Activator of Transcription (Stat)-3 Activates the Receptor Tyrosine Kinase-Like Orphan (ROR)-1 Gene in Chronic Lymphocytic Leukemia (CLL)

被引:0
|
作者
Li, Ping [1 ]
Harris, David [1 ]
Liu, Zhiming [1 ]
Keating, Michael [1 ]
Estrov, Zeev [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:29 / 29
页数:1
相关论文
共 50 条
  • [21] Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
    Jeong, Soo Young
    Lee, Kyung-jun
    Cha, Jieum
    Park, So Yoon
    Kim, Hyeong Su
    Kim, Jung Han
    Lee, Jae-Jun
    Kim, Namhyeok
    Park, Sung Taek
    MEDICINA-LITHUANIA, 2022, 58 (12):
  • [22] Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment
    Luo, Dongdong
    Qiu, Xingyang
    Zheng, Qingquan
    Ming, Yue
    Pu, Wencheng
    Ai, Ming
    He, Jianhua
    Peng, Yong
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (13) : 10655 - 10686
  • [23] Signal Transducer and Activator of Transcription (STAT)-3 Induces Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF) Receptor-α Expression in Chronic Lymphocytic Leukemia (CLL) Cells
    Li, Ping
    Liu, Zhiming
    Harris, David
    Ferrajoli, Alessandra
    Wang, Yongtao
    Hazan-Halevy, Inbal
    Grgurevic, Srdana
    Wierda, William G.
    Burger, Jan A.
    O'Brien, Susan
    Faderl, Stefan
    Keating, Michael J.
    Estrov, Zeev
    BLOOD, 2011, 118 (21) : 1658 - 1658
  • [24] MicroRNA Gene Transcription is Regulated by STAT3 in Chronic Lymphocytic Leukemia (CLL) Cells
    Rozovski, Uri
    Calin, George
    Setoyama, Tetsirp
    Abundu, Lucilla
    Harris, David
    Li, Ping
    Liu, Zhiming
    Grgurevic, Srdana
    Ferrajoli, Alesandra
    Faderl, Stefan
    Burger, Jan
    O'Brien, Susan
    Wierda, William
    Keating, Michael
    Estrov, Zeev
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S133 - S133
  • [25] Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)
    Qiao, Jennifer X.
    Witmer, Mark R.
    Lee, Ving
    Wang, Tammy C.
    Reid, Patrick C.
    Arioka, Yuki
    Farr, Glen
    Hill-Drzewi, Melissa
    Schweizer, Liang
    Yamniuk, Aaron
    Cheng, Lin
    Abramczyk, Bozena
    Corbett, Martin
    Calambur, Deepa
    Szapiel, Nicolas
    Ryseck, Rolf
    Ponath, Paul
    Poss, Michael A.
    Carter, Percy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 98
  • [26] Development of Cirmtuzumab Antibody-Drug Conjugates (ADCs) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
    Mian, Yousaf A.
    Widhopf, George F., II
    Thanh-Trang Vo
    Jessen, Katti
    Rassenti, Laura Z.
    Kipps, Thomas J.
    BLOOD, 2018, 132
  • [27] B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT)1 and STAT3 constitutively phosphorylated on serine residues
    Frank, DA
    Mahajan, S
    Ritz, J
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12): : 3140 - 3148
  • [28] Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
    Hojjat-Farsangi, Mohammad
    Jeddi-Tehrani, Mahmood
    Daneshmanesh, Amir Hossein
    Mozaffari, Fariba
    Moshfegh, Ali
    Hansson, Lotta
    Razavi, Seyed Mohsen
    Sharifian, Ramazan Ali
    Rabbani, Hodjattallah
    Osterborg, Anders
    Mellstedt, Hakan
    Shokri, Fazel
    PLOS ONE, 2015, 10 (11):
  • [29] Tumour-specific immune responses against the receptor tyrosine kinase-like orphan receptor 1 in patients with chronic lymphocytic leukaemia - evidence for immune control?
    Zeis, M.
    Siegel, S.
    Wirth, S.
    Schmitz, N.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S432 - S432
  • [30] Epigallocatechin-3-gallate (EGCG) induces apoptosis, disrupts VEGF receptor-Src kinase association and leads to down-regulation of signal transducer and activator of transcription 3 (STAT 3) in chronic lymphocytic leukemia (CLL) B cells.
    Lee, YK
    Bone, ND
    Strege, AK
    Jelinek, DF
    Kay, NE
    BLOOD, 2003, 102 (11) : 430A - 430A